NICE flip-flops to back J&J's Imbruvica in mantle cell lymphoma

14th December 2017 Uncategorised 0

With just-arrived competition in mantle cell lymphoma, Johnson & Johnson’s Imbruvica has snagged reimbursement backing in an important new market.

More: NICE flip-flops to back J&J's Imbruvica in mantle cell lymphoma
Source: fierce